- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Viruses 2014, 6, 2122-2137; doi:10.3390/v6052122
- Classification
-
Landwirtschaft, Veterinärmedizin
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2015
- Creator
-
Gentschev, Ivaylo
Patil, Sadeep S.
Petrov, Ivan
Cappello, Joseph
Adelfinger, Marion
Szalay, Aladar A.
- URN
-
urn:nbn:de:bvb:20-opus-119753
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gentschev, Ivaylo
- Patil, Sadeep S.
- Petrov, Ivan
- Cappello, Joseph
- Adelfinger, Marion
- Szalay, Aladar A.
- Universität Würzburg
Time of origin
- 2015
Other Objects (12)
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas
“Il n’y a pas de chats”: Feline Absence and/as the Space of Zoopoetics
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas
“Il n’y a pas de chats”: Feline Absence and/as the Space of Zoopoetics
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas
“Il n’y a pas de chats”: Feline Absence and/as the Space of Zoopoetics
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy